• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

采用质谱法评估 30 例 IgA 肾病患者 IgA1 铰链糖肽的特定结构。

Evaluation of the specific structures of IgA1 hinge glycopeptide in 30 IgA nephropathy patients by mass spectrometry.

机构信息

Department of Nephrology, Fujita Health University School of Medicine, Toyoake, Aichi, Japan.

出版信息

J Nephrol. 2010 Jan-Feb;23(1):70-6.

PMID:20091489
Abstract

BACKGROUND

Although many reports have described the abnormal structures of O-glycan in the IgA1 hinge region in IgA nephropathy (IgAN), the specific glycopeptide that can be used as a diagnostic biomarker for IgAN has not yet been identified. To pursue this diagnostic approach, we used mass spectrometric analysis to search for specific structures in IgA1 hinge glycopeptides in 30 IgAN patients contrasted with 30 healthy controls.

METHOD

IgA1 hinge glycopeptides were individually purified from the sera of 30 biopsy-proven IgAN patients and 30 healthy controls. The structure of each glycopeptide was analyzed by ion trap mass spectrometry. Sugar conformations in each glycopeptide were estimated by collision-induced dissociation tandem mass spectrometry. Furthermore, to search for specific O-glycans in IgAN patients with a statistical significance, the identified hinge glycopeptides were analyzed by Fisher exact test.

RESULT

A total of 57 hinge glycopeptides were identified from each of the 2 sample groups. Among the structures of the hinge glycopeptides identified, statistical significance was found for 6 glycopeptides (O-glycan compositions were 33-mer hinge core peptides + xGalNAc + yGal + zNeu5Ac; x:y:z = 5:3:3, 5:3:0, 5:2:1, 4:2:2, 3:1:1, 3:1:0) by Fisher exact test (p<0.05). In these 6 O-glycan compositions, 3 compositions (x:y:z = 4:2:2, 3:1:1, 3:1:0) were only observed in IgAN patients and were absent in the 30 controls.

CONCLUSION

Statistically specific O-glycans were identified in 30 IgAN patients compared with 30 controls. These results open the possibility for preparation of lectin and/or antibodies binding to specific glycopeptides in IgAN.

摘要

背景

虽然许多报道描述了 IgA 肾病(IgAN)中 IgA1 铰链区 O-聚糖的异常结构,但尚未确定可作为 IgAN 诊断生物标志物的特定糖肽。为了寻求这种诊断方法,我们使用质谱分析在 30 例活检证实的 IgAN 患者和 30 例健康对照者的 IgA1 铰链糖肽中寻找特异性结构。

方法

从 30 例活检证实的 IgAN 患者和 30 例健康对照者的血清中分别纯化 IgA1 铰链糖肽。通过离子阱质谱分析分析每种糖肽的结构。通过碰撞诱导解离串联质谱法估计每种糖肽中的糖构象。此外,为了寻找具有统计学意义的 IgAN 患者中特定的 O-聚糖,通过 Fisher 精确检验分析鉴定的铰链糖肽。

结果

从每组的 2 个样本中鉴定出总共 57 个铰链糖肽。在所鉴定的铰链糖肽结构中,通过 Fisher 精确检验发现 6 种糖肽具有统计学意义(O-聚糖组成 33 -mer 铰链核心肽+xGalNAc+yGal+zNeu5Ac;x:y:z=5:3:3,5:3:0,5:2:1,4:2:2,3:1:1,3:1:0)(p<0.05)。在这 6 种 O-聚糖组成中,仅在 IgAN 患者中观察到 3 种组成(x:y:z=4:2:2,3:1:1,3:1:0),在 30 名对照者中未见。

结论

与 30 名对照者相比,在 30 名 IgAN 患者中鉴定出具有统计学意义的特异性 O-聚糖。这些结果为制备与 IgAN 中特定糖肽结合的凝集素和/或抗体开辟了可能性。

相似文献

1
Evaluation of the specific structures of IgA1 hinge glycopeptide in 30 IgA nephropathy patients by mass spectrometry.采用质谱法评估 30 例 IgA 肾病患者 IgA1 铰链糖肽的特定结构。
J Nephrol. 2010 Jan-Feb;23(1):70-6.
2
Mass spectrometry analysis of IgA1 hinge region in patients with IgA nephropathy.IgA肾病患者IgA1铰链区的质谱分析
J Nephrol. 2007 Nov-Dec;20(6):689-95.
3
Direct evidence for decreased sialylation and galactosylation of human serum IgA1 Fc O-glycosylated hinge peptides in IgA nephropathy by mass spectrometry.通过质谱法获得的关于IgA肾病患者血清IgA1 Fc O-糖基化铰链肽唾液酸化和半乳糖基化减少的直接证据。
Biochem Biophys Res Commun. 2000 Apr 29;271(1):268-74. doi: 10.1006/bbrc.2000.2613.
4
Serum under-galactosylated IgA1 is increased in Japanese patients with IgA nephropathy.日本IgA肾病患者血清低半乳糖基化IgA1水平升高。
Nephrol Dial Transplant. 2008 Jun;23(6):1931-9. doi: 10.1093/ndt/gfm913. Epub 2008 Jan 4.
5
Analyses of IgA1 hinge glycopeptides in IgA nephropathy by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.通过基质辅助激光解吸/电离飞行时间质谱法分析IgA肾病中的IgA1铰链区糖肽
J Am Soc Nephrol. 1998 Apr;9(4):577-82. doi: 10.1681/ASN.V94577.
6
Mass spectrometry proves under-O-glycosylation of glomerular IgA1 in IgA nephropathy.质谱分析证实IgA肾病中肾小球IgA1存在O-糖基化不足。
Kidney Int. 2001 Mar;59(3):1077-85. doi: 10.1046/j.1523-1755.2001.0590031077.x.
7
Elucidating heterogeneity of IgA1 hinge-region O-glycosylation by use of MALDI-TOF/TOF mass spectrometry: role of cysteine alkylation during sample processing.利用 MALDI-TOF/TOF 质谱阐明 IgA1 铰链区 O-糖基化的异质性:样品处理过程中半胱氨酸烷化的作用。
J Proteomics. 2013 Oct 30;92:299-312. doi: 10.1016/j.jprot.2013.07.013. Epub 2013 Jul 24.
8
IgA-containing immune complexes in the urine of IgA nephropathy patients.IgA肾病患者尿液中含IgA的免疫复合物。
Nephrol Dial Transplant. 2006 Sep;21(9):2478-84. doi: 10.1093/ndt/gfl240. Epub 2006 Jun 6.
9
O-glycosylation of serum IgD in IgA nephropathy.IgA肾病中血清IgD的O-糖基化
J Am Soc Nephrol. 2006 Apr;17(4):1192-9. doi: 10.1681/ASN.2005101115. Epub 2006 Mar 1.
10
O-glycosylation of serum IgA1 antibodies against mucosal and systemic antigens in IgA nephropathy.IgA肾病中针对黏膜和全身抗原的血清IgA1抗体的O-糖基化
J Am Soc Nephrol. 2006 Dec;17(12):3520-8. doi: 10.1681/ASN.2006060658. Epub 2006 Nov 8.

引用本文的文献

1
O-glycosylation of IgA1 and the pathogenesis of an autoimmune disease IgA nephropathy.IgA1 的 O-糖基化与自身免疫性疾病 IgA 肾病的发病机制。
Glycobiology. 2024 Sep 30;34(11). doi: 10.1093/glycob/cwae060.
2
IgG deposits in the mesangium and capillary loops predict poor renal outcome in patients with IgA nephropathy: a single-center retrospective study.系膜和毛细血管袢中的 IgG 沉积可预测 IgA 肾病患者的不良肾脏结局:一项单中心回顾性研究。
Ren Fail. 2020 Nov;42(1):902-911. doi: 10.1080/0886022X.2020.1811120.
3
Mass spectrometry for the identification and analysis of highly complex glycosylation of therapeutic or pathogenic proteins.
质谱法用于鉴定和分析治疗性或致病性蛋白质的高度复杂糖基化。
Expert Rev Proteomics. 2020 Apr;17(4):275-296. doi: 10.1080/14789450.2020.1769479. Epub 2020 May 28.
4
Aberrant Glycosylation of the IgA1 Molecule in IgA Nephropathy.IgA 肾病中 IgA1 分子的异常糖基化。
Semin Nephrol. 2018 Sep;38(5):461-476. doi: 10.1016/j.semnephrol.2018.05.016.
5
Aberrant IgA1 Glycosylation in IgA Nephropathy: A Systematic Review.IgA肾病中异常的IgA1糖基化:一项系统评价。
PLoS One. 2016 Nov 21;11(11):e0166700. doi: 10.1371/journal.pone.0166700. eCollection 2016.
6
New Insights into the Pathogenesis of IgA Nephropathy.IgA肾病发病机制的新见解
Kidney Dis (Basel). 2015 May;1(1):8-18. doi: 10.1159/000382134. Epub 2015 May 1.
7
Identification of distinct glycoforms of IgA1 in plasma from patients with immunoglobulin A (IgA) nephropathy and healthy individuals.免疫球蛋白A(IgA)肾病患者与健康个体血浆中IgA1不同糖型的鉴定。
Mol Cell Proteomics. 2014 Nov;13(11):3097-113. doi: 10.1074/mcp.M114.039693. Epub 2014 Jul 28.
8
The genetics and immunobiology of IgA nephropathy.IgA 肾病的遗传学和免疫生物学。
J Clin Invest. 2014 Jun;124(6):2325-32. doi: 10.1172/JCI74475. Epub 2014 Jun 2.
9
Autoantibodies targeting galactose-deficient IgA1 associate with progression of IgA nephropathy.针对半乳糖缺乏 IgA1 的自身抗体与 IgA 肾病的进展相关。
J Am Soc Nephrol. 2012 Sep;23(9):1579-87. doi: 10.1681/ASN.2012010053. Epub 2012 Aug 16.
10
The pathophysiology of IgA nephropathy.IgA 肾病的病理生理学。
J Am Soc Nephrol. 2011 Oct;22(10):1795-803. doi: 10.1681/ASN.2011050464. Epub 2011 Sep 23.